Mahidol University is a leading medical University in Thailand and is ranked in the top 100 Universities for the continent of Asia. The Department of Nutrition was founded in 1948 and to this day is committed to research that is designed to solve social problems and generate new bodies of knowledge and innovations.
The Max Biocare Institute partnered with researchers in the Department of Nutrition at Mahidol University to trial the effectiveness of various natural product formulas. To find out more information, please visit the Research and Innovation Platform at the MBCI.
Max Biocare & Mahidol University
-
Omega-3 and childhood cognitive function, 2019
-
Rejuvenating Capsules, 2019
-
Supporting healthy blood sugar, 2018
Trial topic
Omega-3 and childhood cognitive function.
Trial center
The Faculty of Public Health, Mahidol University, Thailand.
Objective
To evaluate the effect of Omega-3 supplementation on cognitive function in children.
Sample
School-aged children (6-12 years) willing to participate, with concurrent informed parental consent.
Methods
Clinical intervention will follow a three arm, double blind, randomized design. Participants (n = ~120) will be recruited and allocated to receive either, placebo, low or high dose omega-3, over a 3 months period. Efficacy will be assessed by changes in behavioral test and neurophysiological tests for cognitive function.
Results
This study is registered with the Thai Clinical Trials Register (click here) and currently in progress.
Trial topic Cosmetics - Rejuvenating capsules Trial center The Faculty of Public Health, Mahidol University, Thailand. Objective To study the effects of the cosmetic ‘Rejuvenating capsules’ on skin aging and brightening parameters in adults. Sample Women 30-65 years of age showing mild to moderate aging skin signs (fine lines/wrinkle, brown spots). Methods This study is currently under ethical review and more details will become available following ethical approval.
Trial topic Supporting healthy blood sugar. Trial center The Faculty of Public Health, Mahidol University, Thailand. Objective To investigate the efficacy of Diabecure® to support healthy blood sugar, insulin sensitivity, lipid profiles, oxidative stress, and inflammation. Sample One hundred and ten subjects, aged 20-70 years, were included, and all had fasting blood glucose levels > 100 mg/dL and HbA1C > 5.7%. Methods In double blind, placebo controlled, randomized trial, patients were divided into 2 groups, and each group administered either Diabecure® or placebo for 3 consecutive months (2 tablets daily). Parameters such as blood glucose profiles, insulin resistance, lipid profiles, blood pressure, oxidative stress and inflammatory makers were monitored during and after the trial to analyse treatment effectiveness. Results This study is registered with the Thai Clinical Trials Register (click here) and we have finished intervention for this trial. The outcomes are currently submitted for publication in a peer-review journal and full results will become available shortly.
Contact Details
